Clinical supply note

A procurement manager's perspective on how investing in advanced wound care products from ConvaTec reduces total costs, improves patient outcomes, and protects your hospital's reputation.

Posted 2026-05-26 by Jane Smith

After tracking our hospital's procurement data for six years—analyzing over $180,000 in cumulative wound care spending—I can tell you one thing with certainty: the cheapest option is almost never the cheapest option.

It sounds contradictory. I know. But when you actually map the total cost of treating a chronic wound from admission to closure, the numbers tell a different story than the unit price on a purchase order. Let me show you what I mean.

The Budget Trap: Why Unit Price is a Liar

When I first took over supply procurement back in 2023, my mandate was clear: reduce costs. So I did what any new manager would do—I looked at the pricelists and swapped out our existing advanced wound care dressings for a lower-cost alternative. (Should mention: this was a brand I'd never worked with before, but the savings looked great on paper.)

The unit cost dropped by roughly 22%. I felt pretty good about that Q2 report.

Then the clinical team started talking to me. And not in a good way.

It turns out, the cheaper dressing didn't manage exudate as effectively. Nurses were reporting more frequent changes—sometimes twice what we'd seen before. Longer healing times. More skin maceration around the wound edges. One patient developed a minor infection that required additional intervention. That 'free setup' offer actually cost us more in hidden fees, but in this case, the hidden costs were clinical.

Here's what happened when I stacked up the actual data:

Dressing changes: Increased from 3x/week to 5x/week on average.
Average healing time: Extended by roughly 23%, based on 47 cases over two quarters.
Complication rate: Minor maceration jumped from an occasional issue to affecting 1 in 6 patients.

We didn't just spend more on supplies. We spent more on nursing time. More on ancillary products to manage complications. And—this is the part that's harder to quantify—we spent down our reputation with patients and their families. That matters.

Period.

Scenario A: The Standard Inpatient with a Chronic Venous Leg Ulcer

Let me walk through the scenarios I've seen play out. If you're managing a patient with a standard chronic venous leg ulcer—typical exudate levels, no major infection, standard healing trajectory—you might think any decent foam dressing will do. And honestly? For stable, low-risk wounds, you can get away with a budget option. My experience is based on monitoring about 80 orders for this category. If you're working with a high-acuity caseload, your mileage will vary.

But here's the nuance: even in these 'standard' cases, the total cost of a product like ConvaTec's advanced wound care line (which includes their moldable foam dressings and gentle adhesives) often works out lower over the full treatment cycle. Why? Fewer changes. Better moisture management. Less damage to the periwound skin.

Seeing our budget dressings vs. our previous standard side by side—same patient demographics, same care protocols—made me realize that a dressing change isn't just a product cost. It's a nurse's 15 minutes. It's the cost of the saline. The cost of the secondary dressing. The cost of the waste disposal. Per change, that adds up to an extra $3-4 in hidden expenses. Over 4 weeks at 5 changes vs. 3 changes weekly? That's a difference of about $25 per patient—not including the cost of the dressing itself.

When I compared our Q1 and Q2 results side by side—same vendor type, different specifications—I finally understood why the product details matter so much for the final bill.

Scenario B: The Complex Patient with Fragile Periwound Skin

This is where the cost equation really shifts. For elderly patients, or those on long-term steroids, the skin around the wound is like tissue paper. Standard adhesive dressings can cause medical adhesive-related skin injury (MARSI). I didn't track this metric carefully enough in the beginning. What I can say anecdotally is that we saw a noticeable drop in skin tears when we switched to a gentler adhesive system.

ConvaTec's moldable technology and skin-friendly adhesives (like those in their foam and silicone ranges) make a real difference here. A single case of MARSI can add days to a hospital stay. At an average cost of $1,200+ per inpatient day in the US, preventing one skin injury can save more than the entire annual supply budget for a small unit.

The question isn't whether the premium product is worth the extra $2 per dressing. It's whether you can afford the alternative.

I built a cost calculator after getting burned on supply switches twice. Here's a rough framework I use now:

Base product cost: The unit price (what's on the invoice).
Application cost: Nursing labor × frequency of changes.
Complication cost: Likelihood of skin damage × treatment cost.
Healing time cost: Extended hospital stay or home care costs.
Reputation cost: Harder to measure, but patient satisfaction scores matter for reimbursement.

I wish I had tracked patient feedback more carefully from the start. What I can say anecdotally is that the upgrade to advanced dressings made a noticeable difference in responses on our post-discharge surveys.

Scenario C: The Procurement-First View (When Budget is the Only Constraint)

Look, I get it. Sometimes the budget is the budget. If your CFO has handed down a mandate that no dressing can cost more than $X per unit, you have to work within those limits. I've been there. My experience is based on negotiating with about 15 different vendors over 6 years. I can't speak to how this applies to organizations with radically different purchasing power.

But here's what I'd suggest: don't standardize on the lowest tier across the board. Use it for the stable, predictable wounds (Scenario A). Reserve your budget for higher-quality products for the complex cases (Scenario B). It's a hybrid model that maxims your limited resources.

Even after choosing this approach, I kept second-guessing. What if the clinical team pushed back on having two different product lines? The first month until we saw the data were stressful.

Approved the new system and immediately thought: 'did I make the right call?' Didn't relax until the nursing feedback came back positive and healing times stabilized.

That's the reality of procurement. You make the best call with the data you have.

How to Decide Which Scenario You're In

If you're reading this and wondering which path fits your organization, here's my advice: look at your own data. Pull your last 50-100 wound care cases. Categorize them by complexity. Calculate the total cost of care—not just the supply cost. If you find that your 'standard' cases are healing well but your complex cases are eating your budget alive, you know where to focus.

Don't have the time or resources to run that analysis? Ask your clinical team one question: 'If you could change one product to make your job easier and improve patient outcomes, what would it be?' Their answer will tell you exactly where the biggest gap is.

I've seen organizations like yours spend $8,400 more annually than necessary by chasing lower unit prices on wound care. I've also seen them save significant money by investing in better products and reducing complication rates. The difference is having the right framework for understanding cost.